News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,278 Results
Type
Article (41172)
Company Profile (261)
Press Release (657845)
Section
Business (206157)
Career Advice (2032)
Deals (35707)
Drug Delivery (89)
Drug Development (81298)
Employer Resources (169)
FDA (16254)
Job Trends (15017)
News (348195)
Policy (32928)
Tag
Academia (2613)
Alliances (50091)
Alzheimer's disease (1310)
Approvals (16218)
Artificial intelligence (179)
Bankruptcy (358)
Best Places to Work (11691)
Biotechnology (181)
Breast cancer (213)
Cancer (1592)
Cardiovascular disease (124)
Career advice (1696)
CAR-T (110)
Cell therapy (322)
Clinical research (65239)
Collaboration (609)
Compensation (313)
COVID-19 (2604)
C-suite (142)
Data (1514)
Diabetes (194)
Diagnostics (6395)
Earnings (85565)
Employer resources (146)
Events (111318)
Executive appointments (519)
FDA (17068)
Funding (553)
Gene therapy (224)
GLP-1 (644)
Government (4393)
Healthcare (18880)
Infectious disease (2703)
Inflammatory bowel disease (114)
Interviews (313)
IPO (16488)
Job creations (3750)
Job search strategy (1446)
Layoffs (434)
Legal (7993)
Lung cancer (236)
Manufacturing (218)
Medical device (13310)
Medtech (13315)
Mergers & acquisitions (19520)
Metabolic disorders (515)
Neuroscience (1688)
NextGen: Class of 2025 (6547)
Non-profit (4531)
Northern California (1919)
Obesity (294)
Opinion (191)
Patents (138)
People (57343)
Phase I (20326)
Phase II (28707)
Phase III (21397)
Pipeline (635)
Postmarket research (2588)
Preclinical (8676)
Radiopharmaceuticals (241)
Rare diseases (299)
Real estate (6108)
Regulatory (22133)
Research institute (2373)
Resumes & cover letters (350)
Southern California (1666)
Startups (3612)
United States (17249)
Vaccines (589)
Weight loss (202)
Date
Today (166)
Last 7 days (602)
Last 30 days (2578)
Last 365 days (35016)
2025 (2578)
2024 (35425)
2023 (40336)
2022 (51426)
2021 (56015)
2020 (54498)
2019 (46964)
2018 (35331)
2017 (32509)
2016 (31983)
2015 (38005)
2014 (31860)
2013 (26980)
2012 (29103)
2011 (29781)
2010 (27820)
Location
Africa (729)
Arizona (208)
Asia (38238)
Australia (6257)
California (4400)
Canada (1606)
China (371)
Colorado (199)
Connecticut (210)
Europe (82199)
Florida (633)
Georgia (155)
Illinois (431)
Indiana (249)
Maryland (702)
Massachusetts (3389)
Michigan (188)
Minnesota (324)
New Jersey (1243)
New York (1264)
North Carolina (815)
Northern California (1919)
Ohio (163)
Pennsylvania (1025)
South America (1123)
Southern California (1666)
Texas (649)
Utah (130)
Washington State (437)
699,278 Results for "mesa laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
January 17, 2025
·
1 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
Mesa Laboratories, Inc. will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024.
May 22, 2024
·
1 min read
Business
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024.
April 1, 2024
·
1 min read
Business
Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, February 5, 2024.
December 14, 2023
·
1 min read
Business
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc., a global leader in the design and manufacture of life science tools and critical quality control solutions, announced results for its fourth fiscal quarter and fiscal year ended March 31, 2024.
June 5, 2024
·
22 min read
Business
Mesa Labs Declares Quarterly Dividend - April 04, 2024
Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.
April 4, 2024
·
2 min read
Business
Mesa Laboratories Appoints Mark Capone to its Board of Directors
Mesa Laboratories, Inc., a global leader in the design and manufacturing of life science tools and critical quality control solutions, announced the appointment of Mark Capone to its Board of Directors, effective January 5, 2024.
January 8, 2024
·
2 min read
BioMidwest
Mesa Labs Releases Second Annual Responsible Business Program Brochure
Mesa Laboratories, Inc. announced the release of its second annual Environmental, Social and Governance Program Brochure.
March 15, 2024
·
4 min read
BioMidwest
Mesa Labs Announces Amendment to Credit Facility and Repurchase of Senior Convertible Notes
Mesa Laboratories, Inc. announced the closing of its Amended and Restated Credit Agreement, which provides up to $200 million of senior secured debt through a syndicate of banks led by JPMORGAN CHASE BANK, N.A.
April 8, 2024
·
4 min read
1 of 69,928
Next
